Stay updated on Clinical Trial: Benfotiamine in Alzheimer's Disease
Sign up to get notified when there's something new on the Clinical Trial: Benfotiamine in Alzheimer's Disease page.

Latest updates to the Clinical Trial: Benfotiamine in Alzheimer's Disease page
- Check6 days agoNo Change Detected
- Check13 days agoNo Change Detected
- Check20 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2, indicating a revision in the content.SummaryDifference0.1%
- Check28 days agoNo Change Detected
- Check35 days agoChange DetectedThe webpage has been updated to include new collaborators and investigators associated with a study on Alzheimer's Disease, while significant details about the study's objectives and design have been removed.SummaryDifference44%
- Check42 days agoChange DetectedThe web page has been updated from version 2.14.3 to version 2.14.4.SummaryDifference0.1%
- Check50 days agoChange DetectedThe web page has been updated from version 2.14.2 to version 2.14.3.SummaryDifference0.1%
- Check86 days agoChange DetectedThe page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with a contact email for assistance.SummaryDifference1.0%
- Check100 days agoChange DetectedThe web page now includes a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with contact information for assistance.SummaryDifference1.0%
Stay in the know with updates to Clinical Trial: Benfotiamine in Alzheimer's Disease
Enter your email address, and we'll notify you when there's something new on the Clinical Trial: Benfotiamine in Alzheimer's Disease page.